VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,849 | -31.4% | 91,910 | 0.0% | 0.36% | -13.7% |
| Q2 2023 | $284,002 | -42.6% | 91,910 | 0.0% | 0.42% | -53.0% |
| Q1 2023 | $494,476 | +80829.0% | 91,910 | 0.0% | 0.88% | -29.7% |
| Q4 2022 | $611 | -100.0% | 91,910 | 0.0% | 1.26% | -42.9% |
| Q3 2021 | $1,441,000 | -58.0% | 91,910 | -50.0% | 2.20% | -56.5% |
| Q2 2021 | $3,428,000 | -56.7% | 183,821 | 0.0% | 5.06% | -47.3% |
| Q1 2021 | $7,923,000 | – | 183,821 | – | 9.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |